Cargando…

The Whole Price of Vancomycin: Toxicities, Troughs, and Time

Vancomycin is a glycopeptide antibiotic that is active against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Nephrotoxicity, which is usually reversible, is the most serious common adverse effect of vancomycin. Vancomycin-associated nephrotoxicity prolongs hospital s...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jeffres, Meghan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501899/ https://www.ncbi.nlm.nih.gov/pubmed/28573434 http://dx.doi.org/10.1007/s40265-017-0764-7

Ejemplares similares

Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
por: Barron, Anthony, et al.
Publicado: (2016)

Elevated Vancomycin Trough Concentration: Increased Efficacy and/or Toxicity?
por: Elyasi, Sepideh, et al.
Publicado: (2014)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

Embedding Physical Activity in the Heart of the NHS: The Need for a Whole-System Approach
por: Speake, Helen, et al.
Publicado: (2016)

Vancomycin trough level and loading dose
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Optimization of time to initial vancomycin target trough improves clinical outcomes
por: Cardile, Anthony P, et al.
Publicado: (2015)

Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine()
por: Nevin, Remington L.
Publicado: (2014)

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates
por: Samardzic, Janko, et al.
Publicado: (2016)

“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
por: Ball, Robert, et al.
Publicado: (2022)

Resuming elective surgical services in times of COVID-19 infection
por: Coimbra, Raul, et al.
Publicado: (2020)

Recent Improvements in Marathon Run Times Are Likely Technological, Not Physiological
por: Muniz-Pardos, Borja, et al.
Publicado: (2021)

It’s Time to Change Direction on Agility Research: a Call to Action
por: Young, Warren, et al.
Publicado: (2021)

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis
por: Mitton, Craig, et al.
Publicado: (2014)

Time to Differentiate Postactivation “Potentiation” from “Performance Enhancement” in the Strength and Conditioning Community
por: Prieske, Olaf, et al.
Publicado: (2020)

Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate?
por: Monteleone, Giovanni, et al.
Publicado: (2022)

Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade(®)
por: Melsheimer, Richard, et al.
Publicado: (2018)

Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients
por: Hammond, Drayton A., et al.
Publicado: (2017)

Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation
por: Park, So Jin, et al.
Publicado: (2015)

An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients
por: Huang, Xiaohui, et al.
Publicado: (2021)

888. A Predictive Model for Subtherapeutic Vancomycin Troughs in Adults
por: Crisp, Sarah, et al.
Publicado: (2022)

Traumatic appendicitis is probably not real: an illustrative analysis of coincidental occurrences in nature
por: Naumann, David N, et al.
Publicado: (2023)

Myxosporean parasites in Australian frogs: Importance, implications and future directions
por: Hartigan, Ashlie, et al.
Publicado: (2013)

Prevention and Treatment of Monkeypox
por: Rizk, John G., et al.
Publicado: (2022)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
por: Smit, Cornelis, et al.
Publicado: (2020)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

To leave or not to leave: American Association for the Surgery of Trauma (AAST) panel discussion on personal, parental, and family leave
por: Kheirbek, Tareq, et al.
Publicado: (2023)

EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
por: Seppala, L. J., et al.
Publicado: (2019)

Disaster planning for a surgical surge: when mass trauma threatens to overwhelm your operating rooms
por: Kelley, Katherine M, et al.
Publicado: (2023)

Variations in institutional review board processes and consent requirements for trauma research: an EAST multicenter survey
por: Nahmias, Jeffry, et al.
Publicado: (2018)

Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
por: Benn, Christine Stabell, et al.
Publicado: (2023)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
por: Borén, Jan, et al.
Publicado: (2020)

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis
por: Corrado, Domenico, et al.
Publicado: (2020)

The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin
por: Saito, Syuichiro, et al.
Publicado: (2022)

Relationship between vancomycin-induced nephrotoxicity and vancomycin trough concentration in older adults: A retrospective observational study
por: Dai, Ning, et al.
Publicado: (2023)

Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values
por: Round, Jeff, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_at5r3ganohqeabob4v1mklcden